Seaport Global Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$734K Hold
3,005
2.32% 19
2024
Q2
$575K Sell
3,005
-4,273
-59% -$867K 2.06% 22
2024
Q1
$1.44M Buy
7,278
+2,693
+59% +$493K 2.92% 9
2023
Q4
$789K Buy
+4,585
New +$704K 1.89% 21
2023
Q3
Sell
-1,000
Closed -$219K 100
2023
Q2
$219K Sell
1,000
-515
-34% -$115K 0.64% 59
2023
Q1
$332K Sell
1,515
-357
-19% -$77.5K 1.05% 26
2022
Q4
$390K Buy
1,872
+96
+5% +$21.1K 1.35% 21
2022
Q3
$388K Buy
1,776
+93
+6% +$21.2K 1.58% 9
2022
Q2
$353K Buy
1,683
+291
+21% +$62K 1.32% 17
2022
Q1
$338K Sell
1,392
-4,436
-76% -$1.07M 1.08% 35
2021
Q4
$1.52M Buy
+5,828
New +$1.51M 2.05% 11

Other funds holding RMD

Seaport Global Advisors's RMD Position: Q3 2024 in Review

Seaport Global Advisors held its ResMed (RMD) position steady in Q3 2024 at 3,005 shares worth $734K. The position accounts for 2.32% of the portfolio, ranked #19.

Seaport Global Advisors first reported a position in RMD in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.52M in Q4 2021. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Seaport Global Advisors held 3,005 shares of ResMed worth $734K as of Q3 2024.
  • Seaport Global Advisors left its ResMed share count unchanged in Q3 2024.
  • ResMed made up 2.32% of Seaport Global Advisors's portfolio in Q3 2024, its #19 holding.
  • Seaport Global Advisors first reported a position in ResMed in Q4 2021 and has held it in 11 quarters since.
  • Seaport Global Advisors's ResMed position peaked at $1.52M in Q4 2021.
  • 802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Seaport Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.